This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
DuPont de Nemours (DD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
DuPont de Nemours (DD) closed the most recent trading day at $78.34, moving +0.9% from the previous trading session.
DuPont de Nemours (DD) Down 7.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Do Options Traders Know Something About DuPont (DD) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to for DuPont (DD) stock based on the movements in the options market lately.
International Flavors (IFF) Beats on Q3 Earnings & Sales, Up Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q3 top line reflects benefits from solid growth in Nourish, Scent and Health & Biosciences as well as additional sales related to the merger with N&B business.
DuPont (DD) Tops Q3 Earnings & Sales Estimates, Cuts FY21 View
by Zacks Equity Research
DuPont (DD) benefits from strong end-market demand amid sustained headwinds from higher input costs and supply chain and logistics issues in Q3. It agrees to buy Rogers for $5.2 billion.
DuPont de Nemours (DD) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 2.68% and 4.34%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
DuPont (DD) Gears Up for Q3 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from higher demand and its cost and productivity actions amid headwinds from higher raw material costs in Q3.
DuPont de Nemours (DD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wall Street Analysts Believe DuPont de Nemours (DD) Could Rally 29%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 29% upside potential for DuPont de Nemours (DD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here's Why You Should Invest In DuPont (DD) Stock Now
by Zacks Equity Research
DuPont (DD) gains from strong demand, cost actions and innovation-driven investment.
DuPont (DD) Inks Deal With NextEra for 135MW of Clean Wind Energy
by Zacks Equity Research
DuPont (DD) signs an agreement with a NextEra subsidiary to generate 135 megawatts of wind power energy as a transition to renewable sources.
International Flavors (IFF) Updates 2021 Sales & EBITDA Guidance
by Zacks Equity Research
International Flavors (IFF) expects sales growth higher than 8% in 2021 and adjusted operating EBITDA margin to be approximately 21.5%.
4 Diversified Chemical Stocks to Watch Out for Amid Industry Woes
by Anindya Barman
Raw material cost pressure and demand worries due to chip shortage and the spread of the Delta variant pose as headwinds for the Zacks Chemicals Diversified industry. DOW, OLN, CC and AVNT are poised to survive the industry challenges.
Why Is DuPont de Nemours (DD) Down 1.1% Since Last Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
International Flavors (IFF) to Divest Microbial Control Business
by Zacks Equity Research
International Flavors' (IFF) latest deal enables it to focus on core business operations by strengthening the balance sheet, while maximizing shareholder returns.
International Flavors (IFF) Q2 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q2 top-line results reflect benefits from solid growth in Scent and Nourish as well as additional sales related to the merger with DuPont's Nutrition & Biosciences (N&B) business.
DuPont (DD) Tops Q2 Earnings & Sales Estimates, Raises FY21 View
by Zacks Equity Research
DuPont (DD) gains on a recovery in key end-markets such as automotive, construction and industrial and sustained strength in semiconductor and smartphones in Q2.
DuPont de Nemours (DD) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 12.77% and 3.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Why DuPont (DD) Might Surprise This Earnings Season
by Zacks Equity Research
DuPont (DD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Albemarle (ALB) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher volumes and prices in its lithium business in the second quarter.
Chemical Stock Q2 Earnings Due on Aug 3: DD, FMC, WLK & KWR
by Anindya Barman
Strong end-market demand and the benefits of strategic measures are likely to have aided the performance of chemical companies in Q2. Let's see how DD, FMC, WLK and KWR are poised ahead of their earnings releases.
3 Chemical Stocks Likely to Outshine Q2 Earnings Estimates
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to reflect on the Q2 performance of Westlake (WLK), DuPont (DD) and Eastman Chemical (EMN).
DuPont (DD) Warms Up to Q2 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from its cost and productivity actions and higher demand in Q2 amid headwinds from higher raw material costs.
DuPont de Nemours (DD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
DuPont de Nemours (DD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Materials ETFs Set to Gain As Q2 Earnings Unfold
by Sweta Killa
With earnings surprises in the cards for many companies, materials ETFs might see smooth trading in the weeks ahead.